Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance
Abstract
The current situation in India shows that there is excess
use and availability of Watch group of antibiotics compared to Access group of antibiotics. Indian authorities
should consider revising the National EML and adopt
the WHO EML for antibiotics in three categories
(AWaRe) to optimize the use of antimicrobials. Measures should be taken by regulators and policy makers to
improve the availability and use of Access group of antibiotics and at the same time decrease the use of Watch
group of antibiotics that have higher resistance potential
in both public and private sector